We reversed the changes in NAD+ levels in Hint2−/− livers and hepatocytes by supplementing the substrate for NAD+ synthesis with exogenous NMN, which restored SIRT3 activity and attenuated HFD-induced MASLD. Here, SIRT3 is linked to metabolic dysfunction-associated steatotic liver disease.